These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12822514)

  • 1. Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells.
    Joe AK; Liu H; Xiao D; Soh JW; Pinto JT; Beer DG; Piazza GA; Thompson WJ; Weinstein IB
    J Exp Ther Oncol; 2003; 3(2):83-94. PubMed ID: 12822514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.
    Lim JT; Piazza GA; Han EK; Delohery TM; Li H; Finn TS; Buttyan R; Yamamoto H; Sperl GJ; Brendel K; Gross PH; Pamukcu R; Weinstein IB
    Biochem Pharmacol; 1999 Oct; 58(7):1097-107. PubMed ID: 10484067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.
    Yoon JT; Palazzo AF; Xiao D; Delohery TM; Warburton PE; Bruce JN; Thompson WJ; Sperl G; Whitehead C; Fetter J; Pamukcu R; Gundersen GG; Weinstein IB
    Mol Cancer Ther; 2002 Apr; 1(6):393-404. PubMed ID: 12477052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
    Rahman MA; Dhar DK; Masunaga R; Yamanoi A; Kohno H; Nagasue N
    Cancer Res; 2000 Apr; 60(8):2085-9. PubMed ID: 10786664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.
    Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB
    Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
    Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
    Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
    Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
    Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
    Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exisulind: Aptosyn, FGN 1, Prevatac, sulindac sulfone.
    Drugs R D; 2004; 5(4):220-6. PubMed ID: 15230629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
    J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide.
    Shirin H; Pinto JT; Kawabata Y; Soh JW; Delohery T; Moss SF; Murty V; Rivlin RS; Holt PR; Weinstein IB
    Cancer Res; 2001 Jan; 61(2):725-31. PubMed ID: 11212275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
    Chan DC; Earle KA; Zhao TL; Helfrich B; Zeng C; Baron A; Whitehead CM; Piazza G; Pamukcu R; Thompson WJ; Alila H; Nelson P; Bunn PA
    Clin Cancer Res; 2002 Mar; 8(3):904-12. PubMed ID: 11895925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
    Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
    Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
    Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
    Stoner GD; Budd GT; Ganapathi R; DeYoung B; Kresty LA; Nitert M; Fryer B; Church JM; Provencher K; Pamukcu R; Piazza G; Hawk E; Kelloff G; Elson P; van Stolk RU
    Adv Exp Med Biol; 1999; 470():45-53. PubMed ID: 10709673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis.
    Goluboff ET; Shabsigh A; Saidi JA; Weinstein IB; Mitra N; Heitjan D; Piazza GA; Pamukcu R; Buttyan R; Olsson CA
    Urology; 1999 Feb; 53(2):440-5. PubMed ID: 9933075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.